168.54USD-0.86%Mkt Cap: 16.95B $P/E: 25.971d ago
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products i…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/E
Avg
P/B
Pricier
1M Perf
Lower
$69.40BUSDP/E 25.2
$23.00BUSDP/E 20.0
$18.49BUSD
$15.35BUSDP/E 175.0
$15.16BUSDP/E 31.8
$12.29BUSD
$8.30BUSDP/E 21.1
$8.02BUSD
$7.22BUSDP/E 26.5
$7.09BUSDP/E 469.0
$5.52BUSDP/E 46.8
$3.54BUSDP/E 18.4
$3.48BUSDP/E 11.1
$3.22BUSDP/E 22.4
$2.66BUSDP/E 59.3
$2.70BUSD
$2.54BUSDP/E 17.6
$2.54BUSD
$2.24BUSDP/E 12.1
$1.92BUSDP/E 19.4
$2.00BUSD
$1.77BUSD
$1.88BUSDP/E 21.2
$1.90BUSD
$1.56BUSDP/E 18.4
$1.58BUSD
$1.37BUSDP/E 113.1
$1.27BUSDP/E 13.5
$1.13BUSDP/E 35.6
$1.17BUSDP/E 17.6
$1.23BUSD
$1.09BUSD
$1.07BUSDP/E Infinity
$964.80MUSD
$998.26MUSDP/E 195.2
$991.60MUSD
$912.76MUSDP/E 39.9
$895.85MUSDP/E 14.4
$889.80MUSDP/E 12.2
$814.31MUSDP/E Infinity
$693.02MUSDP/E 6.8
$704.28MUSDP/E 164.2
$522.76MUSDP/E 14.7
$521.87MUSD
$488.71MUSD
$457.03MUSD
$450.66MUSD
$432.38MUSD
$323.33MUSD
$317.55MUSDP/E 43.3
$312.68MUSD
$342.71MUSD
$305.81MUSD
$304.53MUSD
$288.10MUSDP/E 51.7
$308.25MUSDP/E 9.9
$294.94MUSDP/E 15.2
$268.98MUSDP/E 9.7
$250.67MUSDP/E 47.7
$261.08MUSDP/E 13.0
$239.98MUSDP/E 53.8
$196.92MUSD
$194.94MUSD
$194.66MUSD
$182.70MUSDP/E 8.8
$178.18MUSD
$147.49MUSDP/E 18.8
$151.86MUSD
$138.58MUSD
$148.14MUSD
$125.08MUSD
$119.66MUSDP/E 18.6
$100.44MUSD
$97.09MUSD
$85.39MUSDP/E 12.3
$80.64MUSD
$72.08MUSD
$66.94MUSDP/E 56.4
$67.12MUSD
$64.16MUSD
$66.36MUSDP/E 22.8
$55.72MUSD
$60.45MUSD
$48.97MUSD
$53.46MUSD
$50.41MUSD
$42.17MUSD
$43.54MUSD
$35.03MUSDP/E Infinity
$32.51MUSD
$29.51MUSD
$25.58MUSDP/E 221.0
$23.08MUSD
$23.13MUSD
$21.73MUSD
$21.66MUSD
$18.56MUSD
$16.34MUSD
$14.36MUSDP/E 17.5
$13.58MUSD
$12.11MUSD
$11.27MUSD
$11.45MUSD
$9.80MUSD
$8.90MUSD
$7.07MUSDP/E 0.3
$6.32MUSD
$5.89MUSD
$4.95MUSDP/E 4.0
$5.64MUSDP/E Infinity
$3.29MUSDP/E 1.4
$2.15MUSD
$1.93MUSD
$1.90MUSDP/E 32.5
$1.54MUSD
$668.8KUSD
$216.1KUSDP/E 0.0
$350USD
Indicators:|
Key Statistics
Company
Market Cap16.95B $
Enterprise Value16.09B $
Revenue (TTM)3.10B $
Gross Profit2.81B $
Net Income (TTM)478.60M $
Revenue/Share31.12 USD
Last Price168.54 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS64125C1099
Valuation
P/E (Trailing)25.97
P/E (Forward)13.38
PEG0.48
EV/EBITDA19.42
EV/Revenue5.19
P/S5.46
P/B4.98
EPS (TTM)6.49
EPS (Forward)12.60
52W Range
122.1494% of range171.50
52W High171.50 USD
52W Low122.14 USD
Profitability
Gross Margin98.18%
Oper. Margin22.84%
EBITDA Margin26.71%
Profit Margin16.73%
ROE14.71%
ROA10.33%
Growth
Revenue Growth42.20%
Earnings Growth2310.50%
Cash Flow & Leverage
Operating CF782.70M $
CapEx (TTM)34.00M $
FCF Margin19.04%
FCF Yield3.48%
Net Debt-852.70M $
Net Debt/EBITDA-1.03
Balance Sheet
Debt/Equity0.13
Current Ratio2.93
Quick Ratio2.51
Book Value/Sh33.87 USD
Cash/Share13.09 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateDec 29, 1995
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)195.06 USD
Upside (mean)+15.7%
Target Range144.00 USD – 250.65 USD
$144.00+15.7% to mean$250.65
# Analysts28
Ownership
Shares Out.100.55M
Float99.30M
Insiders1.08%
Institutions103.91%
Short Interest
Short Ratio5.0d
Short % Float7.37%
Short % Out.5.66%
Shares Short5.69M
Short (prev mo.)5.16M
Technical
SMA 50151.83 (+11.0%)
SMA 200142.00 (+18.7%)
Beta0.40
S&P 52W Chg20.05%
Avg Vol (30d)1.02M
Avg Vol (10d)1.35M
Technical Indicators
RSI (14)63.0
MACD3.7554
MACD Signal3.5016
MACD Hist.+0.2537
BB Upper171.04 USD
BB Middle162.86 USD
BB Lower154.67 USD
BB Width10.05%
ATR (14)4.635 USD
Vol Ratio (20d)0.91x